Somewhat Positive News Coverage Somewhat Unlikely to Affect Orthofix International (OFIX) Stock Price

Media coverage about Orthofix International (NASDAQ:OFIX) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Orthofix International earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 46.514007204985 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news stories that may have impacted Accern’s rankings:

NASDAQ OFIX opened at $58.78 on Friday. The firm has a market cap of $1,058.84, a PE ratio of 178.13, a price-to-earnings-growth ratio of 3.23 and a beta of 0.24. Orthofix International has a twelve month low of $36.10 and a twelve month high of $61.00.

Orthofix International (NASDAQ:OFIX) last released its quarterly earnings results on Monday, February 26th. The medical device company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $116.90 million during the quarter, compared to analysts’ expectations of $116.93 million. Orthofix International had a return on equity of 10.66% and a net margin of 1.43%. The company’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.42 EPS. research analysts predict that Orthofix International will post 1.84 earnings per share for the current year.

Several brokerages have issued reports on OFIX. TheStreet upgraded Orthofix International from a “c+” rating to a “b” rating in a report on Tuesday, March 20th. BidaskClub upgraded Orthofix International from a “hold” rating to a “buy” rating in a report on Friday, March 16th. SunTrust Banks upped their target price on Orthofix International to $67.00 and gave the company a “buy” rating in a report on Monday, March 5th. ValuEngine upgraded Orthofix International from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, Gabelli restated a “buy” rating on shares of Orthofix International in a report on Wednesday, February 28th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $57.42.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by BBNS and is owned by of BBNS. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://baseballnewssource.com/2018/03/30/orthofix-international-ofix-earning-somewhat-favorable-news-coverage-analysis-shows/1973538.html.

Orthofix International Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Insider Buying and Selling by Quarter for Orthofix International (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Tampa Bay Starting Relievers In Place of Starters
Tampa Bay Starting Relievers In Place of Starters
Teen Juan Soto Hits Home Run in First At-Bat
Teen Juan Soto Hits Home Run in First At-Bat
Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old


Leave a Reply

 
© 2006-2018 BBNS.